Kavita Sachdeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kavita Sachdeva has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Deepankar Chandrakapure
Department of ENT, Netaji Subhash Chandra Bose Medical College, Jabalpur, India
4 shared publications - Amrita Shukla
Department of Pharmacology, Rameshwaram Institute of Technology and Management, Lucknow, India
3 shared publications - Tinnu Anna Saji
Department of ENT, NSCB MCH, Jabalpur, India
3 shared publications - Lakshmy V. Raj
Department of Otorhinolaryngology and Head and Neck Surgery, Netaji Subash Chandra Bose Medical College, Jabalpur, Madhya Pradesh, India
2 shared publications Mayur V. Kabade
Department of Otorhinolaryngology and Head and Neck Surgery, Netaji Subhash Chandra Bose Medical College, Jabalpur, Madhya Pradesh, India
2 shared publicationsNeeraj Sachdeva
Hitkarini Dental College, Jabalpur, India
2 shared publications
Latest Publications
- 8 April 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (5) , 2088-2096
Submucosal Uncinectomy: An Adjunct to Endoscopic Endonasal Dacryocystorhinostomy
Background Epiphora occurs either because of mechanical obstruction of the lacrimal drainage system or caused by lacrimal pump failure. Dacryocystorhinostomy is the surgical intervention for epiphora resulted due to obstruction of nasolacrimal duct. The operative approach can be either external or endonasal. The endoscopic endonasal dacryocystorhinostomy (EEDCR) was introduced in late 1800s. The key to successful outcome is wide exposure of lacrimal crest and proper apposition of flaps to prevent restenosis. Our study is intended to showcase the advantages of submucosal removal of uncinate bone during EEDCR. Materials and methods This is a prospective randomised interventional study conducted on 59 patients with epiphora and proximal nasolacrimal duct obstruction. Major Pre-op examinations included irrigation tests and endoscopic examination of nasal cavity. The patients were divided into two groups: Group-A(28 patients) underwent routine DCR surgery with classical mucosal flap overlapping, and Group-B(31 patients) underwent EEDCR with submucosal uncinectomy. Results Subjective improvement at 3-month follow-up showed that 30/31 patients in Group-B (96.7%) and 21/28 patients in Group-A (75%) had fully improved. While objective improvement at 3 month shows 22 patients in Group-A(78.5%) had full improvement and 31 patients in Group-B 100% had full improvement. The difference in the results of both groups is statisctically significant. Conclusion The submucosal uncinectomy during DCR surgery is a simple modification of existing technique which helps in proper marsupialization of lachrymal-sac and cover all raw area with mucosa, thus preventing stenosis of neo-ostium. This in turn improves the outcome of the surgery.
- 8 April 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (5) , 2088-2096
Submucosal Uncinectomy: An Adjunct to Endoscopic Endonasal Dacryocystorhinostomy
Background Epiphora occurs either because of mechanical obstruction of the lacrimal drainage system or caused by lacrimal pump failure. Dacryocystorhinostomy is the surgical intervention for epiphora resulted due to obstruction of nasolacrimal duct. The operative approach can be either external or endonasal. The endoscopic endonasal dacryocystorhinostomy (EEDCR) was introduced in late 1800s. The key to successful outcome is wide exposure of lacrimal crest and proper apposition of flaps to prevent restenosis. Our study is intended to showcase the advantages of submucosal removal of uncinate bone during EEDCR. Materials and methods This is a prospective randomised interventional study conducted on 59 patients with epiphora and proximal nasolacrimal duct obstruction. Major Pre-op examinations included irrigation tests and endoscopic examination of nasal cavity. The patients were divided into two groups: Group-A(28 patients) underwent routine DCR surgery with classical mucosal flap overlapping, and Group-B(31 patients) underwent EEDCR with submucosal uncinectomy. Results Subjective improvement at 3-month follow-up showed that 30/31 patients in Group-B (96.7%) and 21/28 patients in Group-A (75%) had fully improved. While objective improvement at 3 month shows 22 patients in Group-A(78.5%) had full improvement and 31 patients in Group-B 100% had full improvement. The difference in the results of both groups is statisctically significant. Conclusion The submucosal uncinectomy during DCR surgery is a simple modification of existing technique which helps in proper marsupialization of lachrymal-sac and cover all raw area with mucosa, thus preventing stenosis of neo-ostium. This in turn improves the outcome of the surgery.
- 20 December 2023
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 76 (2) , 1984-1987
Primary Mucinous Eccrine Carcinoma in Nasomaxillary Region: a Rare Case Report and Management Insights
Primary Mucinous eccrine carcinoma (MEC) is a rare malignant neoplasm of skin believed to arise from eccrine sweat gland commonly with periocular involvement. Here we report a case of 60-year male with a recurrence of unilateral nasomaxillary mass and epiphora. Imaging suggested nasolacrimal duct as probable site of origin. Histopathology and immunochemistry confirmed the diagnosis and managed surgically. This case report emphasizes the significance of including primary MEC in the differential diagnosis of nasomaxillary mass for its recurrence nature and histological similarity with metastasis from other viscera.
- 20 December 2023
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 76 (2) , 1984-1987
Primary Mucinous Eccrine Carcinoma in Nasomaxillary Region: a Rare Case Report and Management Insights
Primary Mucinous eccrine carcinoma (MEC) is a rare malignant neoplasm of skin believed to arise from eccrine sweat gland commonly with periocular involvement. Here we report a case of 60-year male with a recurrence of unilateral nasomaxillary mass and epiphora. Imaging suggested nasolacrimal duct as probable site of origin. Histopathology and immunochemistry confirmed the diagnosis and managed surgically. This case report emphasizes the significance of including primary MEC in the differential diagnosis of nasomaxillary mass for its recurrence nature and histological similarity with metastasis from other viscera.
- 19 July 2023
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 75 (4) , 3725-3732
Comparative Study of Injection Triamcinolone and Hyaluronidase Combination with Injection Platelet Rich Plasma (PRP) in Management of Oral Submucous Fibrosis (OSMF)
This study aimed to compare the results of injection triamcinolone and hyaluronidase combination with injection Platelet Rich Plasma (PRP) in management of Oral Submucous Fibrosis (OSMF). Present study was carried out in randomly divided two groups of 30 patients each of OSMF who all are presented with chief complain of reduced mouth opening. Group A patients were given 1 ml of injection triamcinolone and hyaluronidase combination. Group B patients received 1 ml of injection Platelet Rich Plasma. Both injections were given intralesionally once a week for 6 weeks. Results of ANOVA shows significant better results in improving mouth opening in group B patients receiving injection Platelet Rich Plasma as a treatment. In Group A, patients shows improvement in Maximum interincisal distance (MIID) of mean 6.51 ± 1.02 mm as compared to the patients in group B shows improvement in MIID of mean 9.53 ± 1.06 mm (p value < 0.05). Treatment of OSMF with injection Platelet Rich Plasma is a novel method and found to be more efficient than treatment with injection triamcinolone and hyaluronidase combination.
- 19 July 2023
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 75 (4) , 3725-3732
Comparative Study of Injection Triamcinolone and Hyaluronidase Combination with Injection Platelet Rich Plasma (PRP) in Management of Oral Submucous Fibrosis (OSMF)
This study aimed to compare the results of injection triamcinolone and hyaluronidase combination with injection Platelet Rich Plasma (PRP) in management of Oral Submucous Fibrosis (OSMF). Present study was carried out in randomly divided two groups of 30 patients each of OSMF who all are presented with chief complain of reduced mouth opening. Group A patients were given 1 ml of injection triamcinolone and hyaluronidase combination. Group B patients received 1 ml of injection Platelet Rich Plasma. Both injections were given intralesionally once a week for 6 weeks. Results of ANOVA shows significant better results in improving mouth opening in group B patients receiving injection Platelet Rich Plasma as a treatment. In Group A, patients shows improvement in Maximum interincisal distance (MIID) of mean 6.51 ± 1.02 mm as compared to the patients in group B shows improvement in MIID of mean 9.53 ± 1.06 mm (p value < 0.05). Treatment of OSMF with injection Platelet Rich Plasma is a novel method and found to be more efficient than treatment with injection triamcinolone and hyaluronidase combination.
- Open Access
- 22 April 2022
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 8 (5) , 453-458
Factors contributing to poor outcome in COVID associated mucormycosis
Background: Mucormycosis is an uncommon but a fatal fungal infection that usually affects patients with altered immunity. Mucormycosis is proven to be a life-threatening condition. This occurred in the delta variant epidemic of coronavirus in India. This prompted us to conduct a systematic review of deaths in mucormycosis to know its temporal associations in relation to comorbidities, association with drugs being used in COVID-19 and overall characteristics of patients with its outcome. Methods: This retrospective study was conducted over 21 deaths out of 140 mucormycosis patients in the tertiary care centre between time period from May 2021 to July 2021. Based on the detailed history, clinical examination, endoscopic examination, blood investigations and radiological investigations, data was collected and analysed. Results: In the study 19 patients were post covid and 2 were COVID positive at the time of admission to the hospital. 13 patients were having random blood sugars above 300 and 8 were having below 300 mg/dl. 13 patients had diabetic ketoacidosis. The maximum C-reactive protein (CRP) values was 200 and declined on treatment. The prothrombin time international normalized ratio (PT INR) values range between 0.99 and 1.3. Serum electrolytes were found to be normal in most of the patients. In the present study, 3 patients had electrolyte imbalance not responding to treatment. According to computed tomography/magnetic resonance imaging (CT/MRI) findings,12 had pansinusitis, 3 had pansinusitis with orbital cellulitis, 5 had pansinusitis with cavernous sinus thrombosis and 1 had pansinusitis with mandibular osteomyelitis. Conclusions: Early diagnosis, prompt treatment of comorbidities and immediate surgical debridement prevents death in mucormycosis patients.
- 22 April 2022
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 8 (5) , 453-458
Open AccessFactors contributing to poor outcome in COVID associated mucormycosis
Background: Mucormycosis is an uncommon but a fatal fungal infection that usually affects patients with altered immunity. Mucormycosis is proven to be a life-threatening condition. This occurred in the delta variant epidemic of coronavirus in India. This prompted us to conduct a systematic review of deaths in mucormycosis to know its temporal associations in relation to comorbidities, association with drugs being used in COVID-19 and overall characteristics of patients with its outcome. Methods: This retrospective study was conducted over 21 deaths out of 140 mucormycosis patients in the tertiary care centre between time period from May 2021 to July 2021. Based on the detailed history, clinical examination, endoscopic examination, blood investigations and radiological investigations, data was collected and analysed. Results: In the study 19 patients were post covid and 2 were COVID positive at the time of admission to the hospital. 13 patients were having random blood sugars above 300 and 8 were having below 300 mg/dl. 13 patients had diabetic ketoacidosis. The maximum C-reactive protein (CRP) values was 200 and declined on treatment. The prothrombin time international normalized ratio (PT INR) values range between 0.99 and 1.3. Serum electrolytes were found to be normal in most of the patients. In the present study, 3 patients had electrolyte imbalance not responding to treatment. According to computed tomography/magnetic resonance imaging (CT/MRI) findings,12 had pansinusitis, 3 had pansinusitis with orbital cellulitis, 5 had pansinusitis with cavernous sinus thrombosis and 1 had pansinusitis with mandibular osteomyelitis. Conclusions: Early diagnosis, prompt treatment of comorbidities and immediate surgical debridement prevents death in mucormycosis patients.
- Open Access
- 22 April 2022
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 8 (5) , 471-478
Prevalence of hypokalemia in a patients of post COVID-19 mucormycosis receiving injection liposomal-amphotericin B at tertiary care hospital
Background: Hypokalemia is one of the most common electrolyte disturbances seen in clinical practice and in patients receiving liposomal-amphotericin B (L-AMB). The aim of this retrospective study was to examine the prevalence of hypokalemia in patients of post COVID-19 mucormycosis receiving L-AMB and to evaluate common presenting symptoms of hypokalemia in them. Methods: The present study was conducted as a retrospective study on 100 patients of post COVID-19 mucormycosis who received L-AMB for 1st time between May 2021 and August 2021 at department of otorhinolaryngology and head and neck surgery, Netaji Subhash Chandra Bose medical college and hospital, Jabalpur, Madhya Pradesh, India. Results: In the present study, hypokalemia of varying grades occurred in 23% of the patients, making it an adverse event that requires attention and correction. Hypokalemia is reported in middle aged adults, more in males compared to females and at doses less than 2 gm of L-AMB. Majority (91.30%) of the patients of mucormycosis who developed hypokalemia presented with generalized weakness, anorexia and muscle cramps followed by nausea which is seen in 82.60% patients. Constipation, bloating and abdominal pain being other presenting symptoms in them seen in 56.50%, 56.50% and 52.20% patients respectively. Conclusions: Hypokalemia is a common electrolyte disorder occurring in patients receiving L-AMB which if undetected can be life threatening. Adequate medical management of these patients not only requires proper antifungal administration but also management of electrolyte imbalances related to the administration. L-AMB is a life-saving drug provided it is used judicially and with utmost care.
- 22 April 2022
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 8 (5) , 471-478
Open AccessPrevalence of hypokalemia in a patients of post COVID-19 mucormycosis receiving injection liposomal-amphotericin B at tertiary care hospital
Background: Hypokalemia is one of the most common electrolyte disturbances seen in clinical practice and in patients receiving liposomal-amphotericin B (L-AMB). The aim of this retrospective study was to examine the prevalence of hypokalemia in patients of post COVID-19 mucormycosis receiving L-AMB and to evaluate common presenting symptoms of hypokalemia in them. Methods: The present study was conducted as a retrospective study on 100 patients of post COVID-19 mucormycosis who received L-AMB for 1st time between May 2021 and August 2021 at department of otorhinolaryngology and head and neck surgery, Netaji Subhash Chandra Bose medical college and hospital, Jabalpur, Madhya Pradesh, India. Results: In the present study, hypokalemia of varying grades occurred in 23% of the patients, making it an adverse event that requires attention and correction. Hypokalemia is reported in middle aged adults, more in males compared to females and at doses less than 2 gm of L-AMB. Majority (91.30%) of the patients of mucormycosis who developed hypokalemia presented with generalized weakness, anorexia and muscle cramps followed by nausea which is seen in 82.60% patients. Constipation, bloating and abdominal pain being other presenting symptoms in them seen in 56.50%, 56.50% and 52.20% patients respectively. Conclusions: Hypokalemia is a common electrolyte disorder occurring in patients receiving L-AMB which if undetected can be life threatening. Adequate medical management of these patients not only requires proper antifungal administration but also management of electrolyte imbalances related to the administration. L-AMB is a life-saving drug provided it is used judicially and with utmost care.
- 25 January 2022
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 8 (2) , 129-134
A study of otorhinolaryngological diseases with ophthalmic complications: at a tertiary care center
Background: The close proximity of the eyeball and the orbit to the ENT region, makes the involvement of the orbit and there of ophthalmological manifestations common in the practise of Otorhinolaryngology. The diseases of ENT with orbital extension must be considered whenever a patient presents with signs and symptoms of orbital disease such as proptosis, orbital mass, restriction of eye movements, neurological dysfunction of eye, chemosis, vision disturbances or epiphora.Methods: Patients presenting with ophthalmological manifestations due to various ear, nose, throat and head–neck pathologies were constituted in this prospective study which was carried out on 50 patients of the age group 10 years to 60 years with ophthalmological complications along with ENT diseases who came to the department of ENT and department of Ophthalmology of N.S.C.B. Medical College, Jabalpur from August 2019 to August 2021.Results: Males were affected more than female with ophthalmic complications. Sinonasal tumours were the most common cause of orbital complications, of which carcinoma of maxilla was the commonest , followed by sinonasal lymphoma .Nasal obstruction was the most common ENT complaint and proptosis was the commonest orbital sign.Conclusions: A firmer knowledge of orbital anatomy with respect to sinonasal region is required for any surgeon dealing with this important area, for a safer and more secure management in this complex region. Surgery remains the main stay of treatment for sinonasal diseases with orbital complications. Rapid diagnosis and treatment are of utmost importance in preserving vision and life in these patients.
- 25 January 2022
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 8 (2) , 129-134
A study of otorhinolaryngological diseases with ophthalmic complications: at a tertiary care center
Background: The close proximity of the eyeball and the orbit to the ENT region, makes the involvement of the orbit and there of ophthalmological manifestations common in the practise of Otorhinolaryngology. The diseases of ENT with orbital extension must be considered whenever a patient presents with signs and symptoms of orbital disease such as proptosis, orbital mass, restriction of eye movements, neurological dysfunction of eye, chemosis, vision disturbances or epiphora.Methods: Patients presenting with ophthalmological manifestations due to various ear, nose, throat and head–neck pathologies were constituted in this prospective study which was carried out on 50 patients of the age group 10 years to 60 years with ophthalmological complications along with ENT diseases who came to the department of ENT and department of Ophthalmology of N.S.C.B. Medical College, Jabalpur from August 2019 to August 2021.Results: Males were affected more than female with ophthalmic complications. Sinonasal tumours were the most common cause of orbital complications, of which carcinoma of maxilla was the commonest , followed by sinonasal lymphoma .Nasal obstruction was the most common ENT complaint and proptosis was the commonest orbital sign.Conclusions: A firmer knowledge of orbital anatomy with respect to sinonasal region is required for any surgeon dealing with this important area, for a safer and more secure management in this complex region. Surgery remains the main stay of treatment for sinonasal diseases with orbital complications. Rapid diagnosis and treatment are of utmost importance in preserving vision and life in these patients.
- 1 September 2021
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 74 (S2) , 3111-3117
Adverse Drug Reaction of Antifungals in the Management of Black Fungus: A Tertiary Care Centre Experience
In India, COVID-19 has led to a surge in cases of a potentially fatal fungal infection called mucormycosis, popularly known as “black fungus.” Intravenous amphotericin B is the only available drug for salvage therapy. Efforts to improve its therapeutic efficacy and decrease its nephrotoxicity have focussed on the reformulation of AmB in three new lipid formulations such amphotericin B lipid complex (Abelcet), amphotericin B colloidal dispersion (Amphotec), and liposomal amphotericin B (AmBisome). The aim of this study is (1) to evaluate the adverse drug reaction of various formulations of amphotericin B used for the treatment of rhinooculocerebralmucormycosis in Indian population. (2) to evaluate the adverse drug reaction of injectable form of posaconazole. This prospective observational study was done on a random sample of 110 patients who got admitted for the management of rhinooculocerebral mucormycosis in a tertiary care centre of middle india… The patients were assessed for the adverse reactions following the administration of various antifungal medication and the findings were analysed. All the 110 patients had received two forms of Amphotericin B (liposomal Amphotericin B and Amphotericin B lipid complex) and Posaconazole injection. 60 patients had received all three forms of Amphotericin B. Out of the 110 patients who received Liposomal amphotericin B, only 2 patients developed adverse drug reaction while in 110 patients who received Amphotericin B Lipid complex, 7 patients had adverse drug effects. Lyophilised amphotericin B had been administered to 60 patients in which 51 patients developed adverse drug reaction and in them one patient went to congestive cardiac failure. Injection posaconazole had been administered to 110 patients in which 72 patients developed drug reaction. In spite of its proven track record of Amphotericin B, its well-known side effects and toxicity will sometimes require discontinuation of therapy despite a life-threatening systemic fungal infection. Lipid formulations of AmB are better tolerated than AmB deoxycholate but infusional drug reactions have been reported in lipid formulation too. So improved strategies for the management of infusion related adverse events are required.
- 1 September 2021
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 74 (S2) , 3111-3117
Adverse Drug Reaction of Antifungals in the Management of Black Fungus: A Tertiary Care Centre Experience
In India, COVID-19 has led to a surge in cases of a potentially fatal fungal infection called mucormycosis, popularly known as “black fungus.” Intravenous amphotericin B is the only available drug for salvage therapy. Efforts to improve its therapeutic efficacy and decrease its nephrotoxicity have focussed on the reformulation of AmB in three new lipid formulations such amphotericin B lipid complex (Abelcet), amphotericin B colloidal dispersion (Amphotec), and liposomal amphotericin B (AmBisome). The aim of this study is (1) to evaluate the adverse drug reaction of various formulations of amphotericin B used for the treatment of rhinooculocerebralmucormycosis in Indian population. (2) to evaluate the adverse drug reaction of injectable form of posaconazole. This prospective observational study was done on a random sample of 110 patients who got admitted for the management of rhinooculocerebral mucormycosis in a tertiary care centre of middle india… The patients were assessed for the adverse reactions following the administration of various antifungal medication and the findings were analysed. All the 110 patients had received two forms of Amphotericin B (liposomal Amphotericin B and Amphotericin B lipid complex) and Posaconazole injection. 60 patients had received all three forms of Amphotericin B. Out of the 110 patients who received Liposomal amphotericin B, only 2 patients developed adverse drug reaction while in 110 patients who received Amphotericin B Lipid complex, 7 patients had adverse drug effects. Lyophilised amphotericin B had been administered to 60 patients in which 51 patients developed adverse drug reaction and in them one patient went to congestive cardiac failure. Injection posaconazole had been administered to 110 patients in which 72 patients developed drug reaction. In spite of its proven track record of Amphotericin B, its well-known side effects and toxicity will sometimes require discontinuation of therapy despite a life-threatening systemic fungal infection. Lipid formulations of AmB are better tolerated than AmB deoxycholate but infusional drug reactions have been reported in lipid formulation too. So improved strategies for the management of infusion related adverse events are required.
- Open Access
- 23 June 2021
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 7 (7) , 1105-1110
Spectrum of clinical characteristics of chronic suppurative otitis media unsafe type: a retrospective study from a tertiary care teaching hospital in Central India
Background: Chronic suppurative otitis media (CSOM)-unsafe type or atticoantral disease or chronic otitis media-squamosal type is a commonly encountered bone eroding disease of the middle ear whose complications can be potentially fatal. Methods: Retrospective analysis of 80 patients who underwent mastoid exploration in the department of otolaryngology and head and neck surgery, NSCBMCH, Jabalpur between June 2016 and May 2017. Results: Unsafe CSOM is commoner in young males of 16-30-year age group. Foul smelling, scanty, purulent ear discharge was the commonest symptom (97.5%). Attic perforation was the most consistent otoscopic finding (47.5% cases). 15% of our patients had central perforations. Conductive hearing loss was most common (62%) followed by mixed hearing loss (23%) and sensorineural hearing loss (11%). Commonest complication encountered was mastoiditis (27 cases). Mastoidectomy with tympanoplasty was done in almost all cases (97.5%). Attic (96.2%), additus (90%), and antrum (86.2%) were commonly involved by disease process. Incus was found to be most susceptible to erosion (88.5%) while stapes was most resistant (36.25%). Conclusions: Unsafe CSOM presenting late warrant prompt diagnosis and surgical intervention. Unusual presentation like retropharyngeal abscess and trismus should raise suspicion of complicated unsafe CSOM in patients with history of otorrhoea. Canal wall down mastoidectomy with rehabilitation of hearing is the surgery of choice in patients who are unlikely to follow up regularly.
- 23 June 2021
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 7 (7) , 1105-1110
Open AccessSpectrum of clinical characteristics of chronic suppurative otitis media unsafe type: a retrospective study from a tertiary care teaching hospital in Central India
Background: Chronic suppurative otitis media (CSOM)-unsafe type or atticoantral disease or chronic otitis media-squamosal type is a commonly encountered bone eroding disease of the middle ear whose complications can be potentially fatal. Methods: Retrospective analysis of 80 patients who underwent mastoid exploration in the department of otolaryngology and head and neck surgery, NSCBMCH, Jabalpur between June 2016 and May 2017. Results: Unsafe CSOM is commoner in young males of 16-30-year age group. Foul smelling, scanty, purulent ear discharge was the commonest symptom (97.5%). Attic perforation was the most consistent otoscopic finding (47.5% cases). 15% of our patients had central perforations. Conductive hearing loss was most common (62%) followed by mixed hearing loss (23%) and sensorineural hearing loss (11%). Commonest complication encountered was mastoiditis (27 cases). Mastoidectomy with tympanoplasty was done in almost all cases (97.5%). Attic (96.2%), additus (90%), and antrum (86.2%) were commonly involved by disease process. Incus was found to be most susceptible to erosion (88.5%) while stapes was most resistant (36.25%). Conclusions: Unsafe CSOM presenting late warrant prompt diagnosis and surgical intervention. Unusual presentation like retropharyngeal abscess and trismus should raise suspicion of complicated unsafe CSOM in patients with history of otorrhoea. Canal wall down mastoidectomy with rehabilitation of hearing is the surgery of choice in patients who are unlikely to follow up regularly.
- Open Access
- 23 June 2021
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 7 (7) , 1116-1121
Otorhinolaryngological manifestation in COVID-19
Background: Coronaviruses (CoV) disease caused by the seventh member of enveloped RNA coronavirusdisease. The COVID-19 is presented mainly by lower respiratory tract related symptoms such as fever, cough, dyspnea and chest tightness that could progress rapidly to acute respiratory distress syndrome (ARDS) whereas the different upper respiratory tract related symptoms include nasal congestion, sore throat and smell dysfunction. The aim of this study is to contribute to current knowledge about COVID-19 and to study about the otorhinolaryngological manifestations and its effects in COVID-19 patients. Methods: This prospective observational study was done on 644 patients who got admitted to COVID suspect ward of a tertiary care centre in middle India. The patients were assessed for the signs and symptoms and the findings were analysed. Results: Within the included 664 cases, 423 (64%) were males and 241(36%) were females. The maximum number of patients in 50 to 60 years of age ,128(19%). Among which 97% (646) from urban area and 3% (18) from rural area. 564 (85%) were symptomatic with 459 patients had symptoms for 1-4 days,112 patients for 5-10 days,4 patients between 11-15 days. The most common symptoms with which these patients presented were cough (68%), fever (62%), signs of breathlessness (61%). The most common ENT manifestations were sore throat 333 (59%), nasal discharge 120 (12%), anosmia 65 (12%), ear discharge 46 (8%). Conclusions: Even though the most common manifestations of COVID-19 were cough, fever, breathlessness significant proportions of patients do manifest with ENT symptoms like sorethroat, nasal discharge, anosmia, ear discharge which may go unnoticed. Recognizing the cases and addressing them properly is important for curbing the rapid spread of COVID-19 pandemic.
- 23 June 2021
- Published by Medip Academy in International Journal of Otorhinolaryngology and Head and Neck Surgery
- Vol. 7 (7) , 1116-1121
Open AccessOtorhinolaryngological manifestation in COVID-19
Background: Coronaviruses (CoV) disease caused by the seventh member of enveloped RNA coronavirusdisease. The COVID-19 is presented mainly by lower respiratory tract related symptoms such as fever, cough, dyspnea and chest tightness that could progress rapidly to acute respiratory distress syndrome (ARDS) whereas the different upper respiratory tract related symptoms include nasal congestion, sore throat and smell dysfunction. The aim of this study is to contribute to current knowledge about COVID-19 and to study about the otorhinolaryngological manifestations and its effects in COVID-19 patients. Methods: This prospective observational study was done on 644 patients who got admitted to COVID suspect ward of a tertiary care centre in middle India. The patients were assessed for the signs and symptoms and the findings were analysed. Results: Within the included 664 cases, 423 (64%) were males and 241(36%) were females. The maximum number of patients in 50 to 60 years of age ,128(19%). Among which 97% (646) from urban area and 3% (18) from rural area. 564 (85%) were symptomatic with 459 patients had symptoms for 1-4 days,112 patients for 5-10 days,4 patients between 11-15 days. The most common symptoms with which these patients presented were cough (68%), fever (62%), signs of breathlessness (61%). The most common ENT manifestations were sore throat 333 (59%), nasal discharge 120 (12%), anosmia 65 (12%), ear discharge 46 (8%). Conclusions: Even though the most common manifestations of COVID-19 were cough, fever, breathlessness significant proportions of patients do manifest with ENT symptoms like sorethroat, nasal discharge, anosmia, ear discharge which may go unnoticed. Recognizing the cases and addressing them properly is important for curbing the rapid spread of COVID-19 pandemic.
- Open Access
- 18 August 2020
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 74 (S2) , 2177-2183
A Prospective Study to Evaluate the Role of Narrow Band Imaging and Toludine Blue in the Screening of Premalignant and Malignant Lesions of the Oral Cavity in a Tertiary Referral Centre
- 18 August 2020
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 74 (S2) , 2177-2183
Open AccessA Prospective Study to Evaluate the Role of Narrow Band Imaging and Toludine Blue in the Screening of Premalignant and Malignant Lesions of the Oral Cavity in a Tertiary Referral Centre